Cargando…
GPR64, Screened from Ewing Sarcoma Cells, Is a Potential Target for Antibody-Based Therapy for Various Sarcomas
SIMPLE SUMMARY: New strategies for immunotherapy have led to an increased interest in tumor-specific antigens on the cell surface in the field of oncology. Identifying markers in sarcomas is difficult because their tumor mutation burden is less than that of carcinomas. We assumed that a target prote...
Autores principales: | Nakamura, Koichi, Asanuma, Kunihiro, Okamoto, Takayuki, Yoshida, Keisuke, Matsuyama, Yumi, Kita, Kouji, Hagi, Tomohito, Nakamura, Tomoki, Sudo, Akihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834492/ https://www.ncbi.nlm.nih.gov/pubmed/35159080 http://dx.doi.org/10.3390/cancers14030814 |
Ejemplares similares
-
Do coagulation or fibrinolysis reflect the disease condition in patients with soft tissue sarcoma?
por: Asanuma, Kunihiro, et al.
Publicado: (2022) -
Expression of Interleukin-6 and the Interleukin-6 Receptor Predicts the Clinical Outcomes of Patients with Soft Tissue Sarcomas
por: Nakamura, Koichi, et al.
Publicado: (2020) -
Significance of coagulation and fibrinolysis markers for benign and malignant soft tissue tumors
por: Asanuma, Kunihiro, et al.
Publicado: (2021) -
Prognostic Significance of Thrombomodulin mRNA in High‐Grade Soft Tissue Sarcomas after 10 years
por: Asanuma, Kunihiro, et al.
Publicado: (2020) -
Soluble programmed death-ligand 1 rather than PD-L1 on tumor cells effectively predicts metastasis and prognosis in soft tissue sarcomas
por: Asanuma, Kunihiro, et al.
Publicado: (2020)